Pharmacological Research

Article	Citations
Impact of Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease	337
G-protein biased signaling agonists of Dopamine D3 receptor promote distinct activation patterns of ERK1/2	334
Congenital diaphragmatic hernia increases the sensitivity of pulmonary arteries to nitric oxide	318
Decoding the Metabolic-immune Axis: Neutrophil glycolysis-driven tumor niche remodeling and its therapeutic exploitation	249
Editorial Board	238
Response to letter to the editor: Letter by Chen et al. regarding article, “Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer's disease: A pop	218
Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression	195
Genetic and pharmacological targeting of HINT2 promotes OXPHOS to alleviate inflammatory responses and cell necrosis in acute pancreatitis	189
Paeoniflorin as a potential therapeutic agent for cerebrovascular diseases: A comprehensive review	187
Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer	179
Spatial proteomic profiling reveals conserved prognostic immune microenvironment features across molecular subtypes in small cell lung cancer	174
Organ-targeted biomarkers of sepsis: A systematic review reveals the value of inflammation and lipid metabolic dysregulation	171
Progress in the development of modulators targeting Frizzleds	161
Corrigendum to ‘Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70′ [Pharmacol. Res. 100 (2015) 341–352]	153
An account on the history of pharmacology in Spain	150
Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?	143
ARID1A is a coactivator of STAT5 that contributes to CD8+ T cell dysfunction and anti-PD-1 resistance in gastric cancer	137
Time-dependent proteomics and drug response in expanding cancer cells	137
Protective effect and mechanisms of puerarin in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis of animal studies	134
Research progress on the interaction between oxidative stress and platelets: Another avenue for cancer?	132
DNMT3a-mediated methylation of TCF21/hnRNPA1 aggravates hepatic fibrosis by regulating the NF-κB signaling pathway	129
Pharmacological rationale for the very early treatment of acute coronary syndrome with monoclonal antibodies anti-PCSK9	126
Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales	122
Discovery, development, and characterization of potent and selective USP11 inhibitors	122
Simultaneously blocking ANGPTL3 and CD47 prevents the progression of atherosclerosis through regulating lipid metabolism, macrophagic efferocytosis and lipid peroxidation	118

Combined effects of clonal hematopoiesis of indeterminate potential and P2Y12 inhibitors on outcomes of patients with ST-segment elevation myocardial infarction: A prospective study	116
Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect	113
NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors	105
Natural HSP90 inhibitors as a potential therapeutic intervention in treating cancers: A comprehensive review	105
Natural products targeting RAS by multiple mechanisms and its therapeutic potential in cancer: An update since 2020	105
Echinatin inhibits the growth and metastasis of human osteosarcoma cells through Wnt/β-catenin and p38 signaling pathways	104
Therapeutic implications of sonic hedgehog pathway in metabolic disorders: Novel target for effective treatment	102
Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death	101
An oncolytic system produces oxygen selectively in pancreatic tumor cells to alleviate hypoxia and improve immune activation	100
Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer	99
The function and therapeutic potential of transfer RNA-derived small RNAs in cardiovascular diseases: A review	98
Astaxanthin: A promising therapeutic agent for organ fibrosis	97
Rapid 64Cu radiolabeling and in vivo evaluation of DSPE–NODAGA liposomes in a murine mammary tumor model	96
Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 Via the JAK2-STAT3-PDL1	92
Fluvoxamine alleviates bleomycin-induced lung fibrosis via regulating the cGAS-STING pathway	92
Molecular mechanisms underlying hepatoprotective activity of lutein in the context of intestinal failure-associated liver disease	91
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer	91
Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy	91
Chronic caffeine consumption prevents obesity-induced cognitive and memory impairments by reducing neuroinflammation and enhancing neuronal activity in the hippocampus	90
Corrigendum to “Impaired PARP1-dependent DNA repair in MORC2 mutations drives axonal degeneration in Charcot-Marie-Tooth disease subtype 2Z and spinal muscular atrophy-like neuromotor disorders” [Phar	88
Sex differences in the weight response to GLP-1RA in people with type 2 diabetes. A long-term longitudinal real-world study	88
The specific deletion of cyclooxygenase-1 in megakaryocytes/platelets reduces intestinal polyposis in Apc mice	86
Fig-derived exosome-like nanoparticles attenuating bone metastasis of breast cancer through establishing an anti-tumor microenvironment	86
Phloretin ameliorates diabetes-induced endothelial injury through AMPK-dependent anti-EndMT pathway	84
Molecular mechanisms of pyroptosis in non-alcoholic steatohepatitis and feasible diagnosis and treatment strategies	83
Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD	83
Gut-vascular axis and postbiotics: The need for clear definitions and further research	83
The role of exosomes derived from various sources in facilitating the healing of chronic refractory wounds	82
Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis	82
Sailing south from regulations to strategies: Macau as a promising gateway for the export of proprietary Chinese medicines to ASEAN countries	81
Blocking ANGPTL3 and CD47 impact on atherosclerosis-correspondence	81
IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic pain	79
Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges	79
Single-cell RNA sequencing highlights the roles of C1QB and NKG7 in the pancreatic islet immune microenvironment in type 1 diabetes mellitus	78
Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?	78
Microsomal glutathione transferase 1 controls metastasis and therapeutic response in melanoma	77
Profiling the impact of anti-human CD20 monoclonal antibodies on lymphocyte B cell subsets and their precursors in the bone marrow and in lymphoid tissues in an immunocompromised mouse engrafted with	76
Expand available targets for CAR-T therapy to overcome tumor drug resistance based on the "Evolutionary Traps"	76
Naphthoquinone derivatives as P-glycoprotein inducers in inflammatory bowel disease: 2D monolayers, 3D spheroids, and in vivo models	75
Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer	75
The major histocompatibility complex participates in Parkinson’s disease	75
RNA-binding motif 4 promotes angiogenesis in HCC by selectively activating VEGF-A expression	75
Elevated activity of plasma dipeptidyl peptidase 4 upon stress can be targeted to reverse tumor immunosuppression	75
Editorial Board	74
Regulation of nicotinic acetylcholine receptors by post-translational modifications	74
DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic review	73
Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease	73
Pharmacological targeting of HMGB-1 translocation: A potential therapeutic strategy for COVID-19	73
α1-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α1B/D-adrenoceptors via interference with heteromer formation	72
The complementary and alternative roles of elemene injection in cancer: An umbrella review	72

Corrigendum to “Deficiency in adiponectin exaggerates cigarette smoking exposure-induced cardiac contractile dysfunction: Role of autophagy” [Pharm. Res. 100 (2015) 175–89]	72
Corrigendum to ‘Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein’ [Pharmacol. Res. 175 (2022) 105975]	71
Pharmacological targeting of G protein-coupled receptor heteromers	70
Medical treatment of weight loss in children and adolescents with obesity	70
Nasal accumulation and metabolism of Δ9-tetrahydrocannabinol following aerosol (‘vaping’) administration in an adolescent rat model	70
WITHDRAWN: Red blood cell-derived extracellular vesicles deliver NUP85 siRNA to alleviate MASLD through downregulating SLC27A1/PPAR-γ in hepatocyte	70
Crosstalk mechanisms among gut microbiota, novel programmed cell death, and macrophage polarization	69
TSPO-mediated mitochondrial retrograde signaling primes the microglial NLRP3 inflammasome	69
Combining choline bitartrate and vitamin B12 ameliorates cognitive impairment in hypertensive elders with cognitive frailty	68
Purinosomes and mitochondria: Dynamic interactomes at the crossroads of metabolism, cell structure, and disease	68
A molecular perspective on mGluR5 regulation in the antidepressant effect of ketamine	67
Sex-dependent efficacy of sphingosine-1-phosphate receptor agonist FTY720 in mitigating Huntington’s disease	67
Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy	67
Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): Recommendations from Italian scientific societies, patient as	67
Hormesis: wound healing and fibroblasts	66
Role of Angiopoietin-Tie axis in vascular and lymphatic systems and therapeutic interventions	66
TAK1 blockade as a therapy for retinal neovascularization	65
CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential	64
A copper nanocluster-based multifunctional nanoplatform for augmented chemo/chemodynamic/photodynamic combination therapy of breast cancer	64
The action of curcumin against damage resulting from cerebral stroke: A systematic review	64
Ginsenoside Ro prevents endothelial injury via promoting Epac1/AMPK- mediated mitochondria protection in early diabetic retinopathy	63
Hormesis: Wound healing and keratinocytes	63
Revisiting the renin-angiotensin-aldosterone system in the eye: Mechanistic insights and pharmacological targets	62
Hydrogen sulfide regulates the redox state of soluble guanylate cyclase in CSE-/- mice corpus cavernosum microcirculation	62
Ferritin nanoconjugates guide trastuzumab brain delivery to promote an antitumor response in murine HER2 + breast cancer brain metastasis	62
Beyond the HPA axis: Synaptic circuits of PVNCRH neurons in stress-related psychiatric disorders	61
Gut microbiota and their metabolites in stroke: From mechanistic study toward therapeutic perspectives	61
Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC	61
Astrocyte-derived lactoferrin inhibits neuronal ferroptosis by reducing iron content and GPX4 degradation in APP/PS1 transgenic mice	61
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy	61
Targeted and cytotoxic inhibitors used in the treatment of lung cancers	60
Fei-Yan-Qing-Hua decoction inhibits influenza viral replication by enhancing NK cell maturation and activation through the upregulation of JAK/STAT/T-bet signalling axis	60
Sirtuin3 attenuates pressure overload-induced pathological myocardial remodeling by inhibiting cardiomyocyte cuproptosis	60
Role of hypoxia in cellular senescence	60
IUPHAR editorial: Emerging targets for the treatment of pain: Moving towards non-addicting therapeutics and new preclinical directions	59
A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME	59
Atrial fibrillation: Epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors	59
Pharmacological targeting of microglia dynamics in Alzheimer’s disease: Preclinical and clinical evidence	59
Commentary on “Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis”	59
Astrocytic connexin43 in the medial prefrontal cortex regulates depressive- and anxiety-like behaviors via ATP release	59
Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics	59
Editorial Board	58
Therapeutical peptides – Rapidly developing pharmaceutical landscape	58
Design of the distribution of iron oxide (Fe3O4) nano-particle drug in realistic cholangiocarcinoma model and the simulation of temperature increase during magnetic induction hyperthermia	58
Gut microbiota and well-being: A comprehensive summary of the special issue	58
Targeting LRP6: A new strategy for cancer therapy	57
TRP channels in cancer: Therapeutic opportunities and research strategies	57
Game-changer in the fight against Huntington's disease: Cholesterol nanoparticles restore brain function in mice	56
Efficacy and safety of Qingda granule versus valsartan capsule in Chinese grade 1 hypertensive patients with low-moderate risk: A randomized, double-blind, double dummy, non-inferiority, multi-center	56
Editorial Board	54
Editorial Board	53
Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3	53
Special Issue Spanish Basic and Clinical Pharmacology	53
Dietary lipid droplet structure in postnatal life improves hepatic energy and lipid metabolism in a mouse model for postnatal programming	52
ER-organelle contacts: A signaling hub for neurological diseases	52
Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study	51
Corrigendum to “Ectopic expression of NKG7 enhances CAR-T function and improves the therapeutic efficacy in liquid and solid tumors” [Pharmacol. Res. 210 (2024) 107506]	50
New therapies towards a better glycemic control in youths with type 1 diabetes	50
Corrigendum to “A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME” [Pharmacol. Res. 181 (2022) 106269]	50
Corrigendum to “Paclitaxel-Ang-2-functionalized bionic mesoporous selenium nanoparticles for targeted therapy of glioma” [Pharmacol. Res. 216 (2025) 107783]	50
Impaired PARP1-dependent DNA repair in MORC2 mutations drives axonal degeneration in Charcot-Marie-Tooth disease subtype 2Z and spinal muscular atrophy-like neuromotor disorders	49
Anti-inflammatory and immunomodulatory activity of Mangifera indica L. reveals the modulation of COX-2/mPGES-1 axis and Th17/Treg ratio	49
Leveraging HER2-targeted biparatopic antibodies in solid tumors	49
Nanotheranostics in cancer lymph node metastasis: The long road ahead	49
MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis	49
Systematic druggable genome-wide Mendelian randomization to identify therapeutic targets and dominant flora for ulcerative colitis	49
KV11.1 (hERG1)-centered macromolecular membrane complexes regulate proliferation in B cell lymphomas and constitute novel pharmacological targets	48
Hv1 channel in immune cells and pharmacology	48
Cannabidiol and Beta-Caryophyllene: Chronic inflammatory pain	48
Post-stroke administration of H2 relaxin reduces functional deficits, neuronal apoptosis and immune cell infiltration into the mouse brain	48
Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression	48
Role for the F-box proteins in heart diseases	47
Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathway	47
New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?	47
Ferroportin 1 depletion in neural stem cells promotes hippocampal neurogenesis and cognitive function in mice	47
Neutrophils as potential therapeutic targets for breast cancer	47
Potential of diterpenes as antidiabetic agents: Evidence from clinical and pre-clinical studies	47
A panel of altered blood oxysterols in patients with mild cognitive impairment: A novel combined diagnostic marker	47
The α9α10 acetylcholine receptor: A non-neuronal nicotinic receptor	47
Perturbations of CB1 receptor signalling during adolescence impair cortical myelination in female rats	47

Adaptive immunity in osteoarthritis: Mechanisms and opportunities for regulatory T-cell–targeted therapy	47
Anti-neuropathic pain activity of Ajugarin-I via activation of Nrf2 signaling and inhibition of TRPV1/TRPM8 nociceptors in STZ-induced diabetic neuropathy	47
Zedoarondiol inhibits atherosclerosis by regulating monocyte migration and adhesion via CXCL12/CXCR4 pathway	46
Gut microbiota-driven metabolic alterations reveal the distinct pathogenicity of chemotherapy-induced cachexia in gastric cancer	46
Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond	46
Multitarget ligands that comprise opioid/nonopioid pharmacophores for pain management: Current state of the science	46
Kallistatin leads to cognition impairment via downregulating glutamine synthetase	46
Action and therapeutic targets of myosin light chain kinase, an important cardiovascular signaling mechanism	45
IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics	44
MDA-9/Syntenin small molecule inhibitor IVMT-Rx-4 blocks prostate cancer bone metastasis	44
Alternative splicing: A key regulator in T cell response and cancer immunotherapy	44
Protein S-palmitoylation: Dynamic regulatory networks, physiological functions, and new frontiers in targeted therapy	44
Phosphoproteomics identifies Rho-Kinase-associated phospho-signaling and autophagy-associated alterations in the medial prefrontal cortex of a schizophrenia-related mouse model	44
Functional significance of O-linked N-acetylglucosamine protein modification in regulating autophagy	44
Polyol pathway and redox balance in diabetes	44
SGK1-inhibition restores cardiac repolarization in LQT2 rabbits and LQT3 mice by reducing late sodium current	44
Regulation of glycolysis-derived L-lactate production in astrocytes rescues the memory deficits and Aβ burden in early Alzheimer’s disease models	43
The role and potential mechanism of O-Glycosylation in gastrointestinal tumors	43
Understanding the habenula: A major node in circuits regulating emotion and motivation	43
Breaking through the treatment desert of conventional mesothelin-targeted CAR-T cell therapy for malignant mesothelioma: A glimpse into the future	43
Preclinical development of a standardized extract of Ilex paraguariensis A.St.-Hil for the treatment of obesity and metabolic syndrome	43
MAO inhibitors for treatment-resistant depression: Bringing an updated perspective on pioneering drugs	43
Ketogenic diet in children and adolescents: The effects on growth and nutritional status	43
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models	43
Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics	43
Manuka honey activates the aryl hydrocarbon receptor: Implications for skin inflammation	43
The interplay of aging, sleep dysregulation, and mitochondrial dysfunction in metabolic and neurodegenerative diseases	43
Ginsenoside Re binds Drp1 Leu94 across species to restore mitochondrial homeostasis via Atg1/ULK1-dependent fission-mitophagy coupling in age-related degeneration	42
Editorial Board	42
Topical VX-509 attenuates psoriatic inflammation through the STAT3/FABP5 pathway in keratinocytes	42
Clinical trials of orphan drugs in China over the decade 2012–2022: Opportunities and challenges	42
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy	42
An ode to valproic acid: A letter to the editor	42
Corrigendum to “Sugiol, a diterpenoid: Therapeutic actions and molecular pathways involved” Pharmacol. Res. 163 (2021) 105313	42
Mtnr1b deletion disrupts placental angiogenesis through the VEGF signaling pathway leading to fetal growth restriction	42
Paracetamol metabolism by endothelial cells – Potential mechanism underlying intravenous paracetamol-induced hypotension	42
D-arabinose acts as antidepressant by activating the ACSS2-PPARγ/TFEB axis and CRTC1 transcription	42
Inhibition of long noncoding RNA Gm41724 alleviates pressure overload-induced cardiac fibrosis by regulating lamina-associated polypeptide 2α	42
Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer	41
Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis	41
Circulating cytokines and risk of developing hypertension: A systematic review and meta-analysis	41
Editorial Board	41
β-amyloid’s neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review	41
Corrigendum to “Tagitinin F has anti-inflammatory, anti-nociceptive and anti-matrix metalloproteinase properties: An in silico, in vitro and in vivo study” [Pharmacol. Res. 164 (2021) 105303]	41
Gut microbiota-derived metabolite phenylacetylglutamine in cardiovascular and metabolic diseases	41
Diabetic retinopathy in the pediatric population: Pathophysiology, screening, current and future treatments	41
Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders	40
A novel approach to explore metabolic diseases: Neddylation	40
Circulating extracellular vesicles from patients with traumatic brain injury induce cerebrovascular endothelial dysfunction	40
Immunometabolic reprogramming of macrophages: Emerging roles in skeletal muscle regeneration and therapeutic perspectives	40
Ginsenoside Rb1 and berberine synergistically protect against type 2 diabetes mellitus via GDF15/HAMP pathway throughout the liver lobules: Insights from spatial transcriptomics analysis	40
Gut Clostridium sporogenes-derived indole propionic acid suppresses osteoclast formation by activating pregnane X receptor	40
Stem cells therapy in neurodegenerative and neuroimmune diseases: Current status of treatments and future prospects	40
Poly (ADP-ribose) polymerase (PARP) inhibitors approved for the treatment of cancer	39
Therapeutic effects of curcumin liposomes and nanocrystals on inflammatory osteolysis: In vitro and in vivo comparative study	39
Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy	39
A review of KLF4 and inflammatory disease: Current status and future perspective	39
S-glutathionylation in cancer: from fundamental mechanisms to clinical applications	39
A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing	39
ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis	39
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response	39
The ketogenic diet modulates tumor-associated neutrophil polarization via the AMOT-YAP/TAZ axis to inhibit colorectal cancer progression	39
The AIM2 inflammasome: A novel biomarker and target in cardiovascular disease	39
Powering prescription: Mitochondria as “Living Drugs” – Definition, clinical applications, and industry advancements	39
Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?	38
Vanillic acid restores homeostasis of intestinal epithelium in colitis through inhibiting CA9/STIM1-mediated ferroptosis	38
Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions	38
AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease	38
The addicted brain: How processed foods hijack reward pathways	38
SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19	38
Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases	38
Biological activities, Molecular mechanisms, and Clinical application of Naringin in Metabolic syndrome	38
The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives	38
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges	38
Corrigendum to “Modulation of the JAK/ERK/STAT signaling in melanocortin -induced inhibition of local and systemic responses to myocardial ischemia/reperfusion [Pharmacological Research 72 (2013) 1–8]	37
Corrigendum to “Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET/MYC/AXL axis” [Pharmacol. Res. 188 (2023) 106668]	37
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab	37
Correspondence “Validation of fermentation techniques for prebiotic impact on gut microbiota”	37
Targeting EVA1B in breast cancer: New avenues for precision oncology	37
Copper metabolism and its role in diabetic complications: A review	37
The potential role of mitochondria in the microbiota-gut-brain axis: Implications for brain health	37
Investigating the intercalation efficacy of sinomenine with diverse DNA fragments to understand its regulatory role in DNA methylation levels	37
Corrigendum to “GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma”[Pharmacol. Res. 183 (2022) 106389]	37
Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42	36
Improving glioma drug delivery: A multifaceted approach for glioma drug development	36
Novel therapeutic strategies targeting UCP2 in uterine leiomyosarcoma	36
Methodological innovations in AI-assisted Chinese patent medicine prescribing	36
Novel targets for treating neurodegenerative diseases: The PKM2-STAT3-hnRNPA1 feedback loop	36
Photopharmacological manipulation of amygdala metabotropic glutamate receptor mGlu4 alleviates neuropathic pain	36
ENPP2 inhibitor improves proliferation in AOM/DSS-induced colorectal cancer mice via remodeling the gut barrier function and gut microbiota composition	36
Histone lysine crotonylation accelerates ACSL4-mediated ferroptosis of keratinocytes via modulating autophagy in diabetic wound healing	36
Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease	36
Fibroblast growth factor 16: Molecular mechanisms, signalling crosstalk, and emerging roles in cardiac biology and metabolic regulation	36
A TRPV1 agonist from the transcriptome profiling of Dipsastraea rotumana inhibits neuroinflammation in vivo through the NF-κB and MAPK pathways	36
Targeted gut microbiome therapy: Applications and prospects of probiotics, fecal microbiota transplantation and natural products in the management of type 2 diabetes	35